Furthermore, interleukin-17-secreting CD4 + T-cells (Th17) are overexpressed in low-risk MDS patients, which correlates with apoptosis in the bone marrow and lower hemoglobin levels [23,53]. The gene discussed is CD4; the disease is myelodysplastic syndrome.